Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates

Subepithelial infiltrates secondary to adenoviral keratoconjunctivitis may persist for years and cause blurred vision, halos, glare, and photophobia. These infiltrates arise from immune reaction against the virus, and few studies have reported topical cyclosporine A to be effective in the treatment...

Full description

Bibliographic Details
Published in:	Case Reports in Ophthalmology
Main Authors:	Betül N. Bayraktutar, Ömür Ö. Uçakhan
Format:	Article
Language:	English
Published:	Karger Publishers 2016-03-01
Subjects:	Adenoviral keratoconjunctivitis Subepithelial infiltrates Cyclosporine A
Online Access:	http://www.karger.com/Article/FullText/444784

Similar Items

Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis
by: Rahul Bhargava, et al.
Published: (2019-01-01)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
by: Okumus Seydi, et al.
Published: (2012-08-01)

FEATURES OF 0.05% CYCLOSPORINE (RESTASIS) APPLICATION IN TREATMENT OF RECURRENT INFILTRATIVE ADENOVIRAL KERATITIS
by: D. Y. Maychuk, et al.
Published: (2015-10-01)

Evaluating anterior corneal surface using Placido ring mires for irregular astigmatism in refractory corneal subepithelial infiltrates after adenoviral conjunctivitis
by: Noriko Toyokawa, et al.
Published: (2024-11-01)

Evaluating the Efficacy of Topical Tacrolimus Alone and in Combination with Prednisolone for Treating Subepithelial Infiltrates in Epidemic Keratoconjunctivitis
by: Emine Esra Karaca, et al.
Published: (2025-04-01)

In Vivo Confocal Microscopic Findings of Subepithelial Infiltrates Associated with Epidemic Keratoconjunctivitis
by: Sibel Kocabeyoğlu, et al.
Published: (2015-05-01)

Effect of Topical Cyclosporine 0.05% in Allergic Conjunctivitis
by: Sonali Bhalla, et al.
Published: (2015-01-01)

Pathogenesis and management of adenoviral keratoconjunctivitis
by: Chigbu DI, et al.
Published: (2018-07-01)

Topography-Guided Transepithelial Photorefractive Keratectomy for the Treatment of Persistent and Visually-Significant Adenoviral Corneal Infiltrates
by: Spadea L, et al.
Published: (2023-04-01)

<italic>In Vivo</italic> Confocal Microscopy Analysis of the Corneal Layers in Adenoviral Epidemic Keratoconjunctivitis
by: Sevgi Subaşı, et al.
Published: (2018-12-01)

Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis
by: Ilkay Kilic Muftuoglu, et al.
Published: (2016-04-01)

Comparative Efficacy and Safety of Topical Cyclosporine, Dexamethasone and Loteprednol in Vernal Keratoconjunctivitis
by: Muhammad Shahid Naeem, et al.
Published: (2024-12-01)

Comparative Efficacy and Safety of Topical Cyclosporine, Dexamethasone and Loteprednol in Vernal Keratoconjunctivitis
by: Muhammad Shahid Naeem, et al.
Published: (2024-12-01)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
by: Arkendu Chatterjee, et al.
Published: (2019-10-01)

Effect of diluted povidone iodine in adenoviral keratoconjunctivitis on the rate of subepithelial corneal infiltrates
by: Rana Altan-Yaycioglu, et al.
Published: (2019-09-01)

An Update on Viral Conjunctivitis Treatment Strategies: A Narrative Literature Review
by: Maheshver Shunmugam, et al.
Published: (2025-07-01)

Comparison between the Efficacy and Tolerability of Polyvinylpyrrolidone-Iodine Eye Drops 0.6% and 1% in Adenoviral Keratoconjunctivitis: A Randomized Clinical Trial
by: Ali Makateb, et al.
Published: (2024-08-01)

Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitis
by: Amarilla Barcsay-Veres, et al.
Published: (2025-02-01)

Epidemic keratoconjunctivitis: A review of current concepts in management
by: Andria M. Pihos
Published: (2013-04-01)

Changes in tear protein profile in dogs with keratoconjunctivitis sicca following topical treatment using cyclosporine A
by: Metita Sussadee, et al.
Published: (2021-06-01)

Human adenoviral type 54 keratoconjunctivitis accompanied by stellate keratitis and keratic precipitates: two cases
by: Kazuki Matsuura, et al.
Published: (2019-01-01)

Keratopathy in Patients with Adenoviral Keratoconjunctivitis: Evaluation of the Effectiveness of Modern Interferon Preparations
by: E. A. Drozdova, et al.
Published: (2023-04-01)

A STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF TOPICAL CYCLOSPORINE-A 0.5% WITH TOPICAL PLACEBO (ARTIFICIAL TEARS) IN ALLEVIATING THE CLINICAL FEATURES ASSOCIATED WITH VERNAL KERATOCONJUNCTIVITIS
by: Abha Gahlot, et al.
Published: (2016-03-01)

FEATURES OF THE CLINICAL COURSE, OBSERVATION AND PREVENTION OF ADENOVIRAL EPIDEMIC KERATOCONJUNCTIVITIS IN INFANT IN THE PERINATAL CENTER
by: I. B. Astasheva
Published: (2017-12-01)

Efficacy and safety of 0.05% micellar nano-particulate (MNP) cyclosporine ophthalmic emulsion in the treatment of moderate-to-severe keratoconjunctivitis sicca: a 12-week, multicenter, randomized, active-controlled trial
by: A Tarakeswara Rao, et al.
Published: (2023-03-01)

Cyclosporine A and autologous serum efficacy for treatment of vernal keratoconjunctivitis
by: Ahmed Esmail, et al.
Published: (2024-05-01)

The efficacy of combined povidone-iodine 1% and dexamethasone 0.08% prepared eye drops in treating post-viral corneal subepithelial infiltrates
by: Mowaffaq K Alkassasbeh, et al.
Published: (2025-10-01)

Nummular keratitis: A rare manifestation of brimonidine allergy
by: Maitha Al Asmi, et al.
Published: (2024-01-01)

Cicatricial keratoconjunctivitis associated with lichen planus
by: Huang, Susan, et al.
Published: (2015-10-01)

Cyclosporine A (CsA) treatment of chronic autoimune-mediated keratoconjunctivitis sicca in dogs
by: Hadži-Milić M., et al.
Published: (2013-01-01)

The evolving role of ciclosporin in the management of vernal keratoconjunctivitis
by: Mumta Kanda, et al.
Published: (2025-04-01)

Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach
by: Daniele Giovanni Ghiglioni, et al.
Published: (2020-04-01)

Clinical and virological analysis of epidemic keratoconjunctivitis caused by adenovirus type 54 in a regional ophthalmic clinic in Kyushu, Japan
by: Uemura T, et al.
Published: (2018-03-01)

Topical application of 0.05% cyclosporine A as an adjunct to LASIK
by: E. V. Kudryashova, et al.
Published: (2015-12-01)

Topical Cyclosporine A 0.05% for the Treatment of Dry Eye Disease
by: Naeima M. Elzlitni, et al.
Published: (2021-03-01)

Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
by: Yuan-Hsi Chan, et al.
Published: (2023-01-01)

The effect of povidone-iodine 2% eye drops in the treatment of adenoviral keratoconjunctivitis
by: Mohammad Soleimani, et al.
Published: (2023-01-01)

Comparison of effects of cyclosporine 0.05% and 0.1% in dry eye with Sjögren’s syndrome
by: Donghyun Jee, et al.
Published: (2025-07-01)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
by: de Oliveira RC, et al.
Published: (2019-07-01)

Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
by: Ritika Mullick, et al.
Published: (2021-01-01)